Miller, Scott T

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)

Wang, W. C., Ware, R. E., Miller, S. T., Iyer, R. V., Casella, J. F., Minniti, C. P., Rana, S., Thornburg, C. D., Rogers, Z. R., Kalpatthi, R. V., et al. (2011) · The Lancet

Hemoglobinopathies and Related DisordersNeonatal Health and Biochemistry

Cited by 803

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial

Ware, R. E., Davis, B. R., Schultz, W. H., Brown, R. C., Aygun, B., Sarnaik, S., Odame, I., Fuh, B., George, A., Owen, W., et al. (2016) · The Lancet

Hemoglobinopathies and Related DisordersNeonatal Health and Biochemistry

Cited by 515

Prediction of Adverse Outcomes in Children with Sickle Cell Disease

Miller, S. T., Sleeper, L. A., Pegelow, C. H., Enos, L. E., Wang, W. C., Weiner, S. J., Wethers, D. L., Smith, J., & Kinney, T. R. (2000) · New England Journal of Medicine

Hemoglobinopathies and Related DisordersBlood groups and transfusion

Cited by 508

Silent cerebral infarcts in sickle cell anemia: a risk factor analysis

Kinney, T. R., Sleeper, L. A., Wang, W. C., Zimmerman, R. A., Pegelow, C. H., Ohene-Frempong, K., Wethers, D. L., Bello, J. A., Vichinsky, E. P., Moser, F. G., et al. (1999) · PEDIATRICS

Hemoglobinopathies and Related DisordersAcute Ischemic Stroke Management

Cited by 309

Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: A report from the Cooperative Study of Sickle Cell Disease

Miller, S. T., Macklin, E. A., Pegelow, C. H., Kinney, T. R., Sleeper, L. A., Bello, J. A., DeWitt, L. D., Gallagher, D. M., Guarini, L., Moser, F. G., et al. (2001) · The Journal of Pediatrics

Hemoglobinopathies and Related DisordersAcute Ischemic Stroke Management

Cited by 287